bycomet's cast | Paragraph
Avigan approved for the treatment of SFTS (severe febrile thrombocytopenia syndrome), an infectious disease caused by ticks
Date: May 25, 2024
Article Summary
Avigan (favipiravir) has been approved as a treatment for SFTS (severe febrile thrombocytopenia syndrome), an infectious disease transmitted by ticks.
For more information, see the following links:
Detailed Study
Severe fever with thrombocytopenia syndrome (SFTS) is a serious bunyavirus infection that has high mortality rates. Research indicates that Favipiravir has demonstrated effectiveness in preventing and treating SFTS virus (SFTSV) infections in animal models. A multicenter non-randomized, uncontrolled single-arm trial was conducted to collect data on the efficacy and safety of using Favipiravir for treating patients with SFTS.